Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Selective pharmacological targeting of a DEAD box RNA helicase.

PloS one - 13 Feb 2008

Lindqvist Lisa, Oberer Monika, Reibarkh Mikhail, Cencic Regina, Bordeleau Marie-Eve, Vogt Emily, Marintchev Assen, Tanaka Junichi, Fagotto Francois, Altmann Michael, Wagner Gerhard, Pelletier Jerry

Abstract excerpt

RNA helicases represent a large family of proteins implicated in many biological processes including ribosome biogenesis, splicing, translation and mRNA degradation. However, these proteins have little substrate specificity, making inhibition of selected helicases a challenging problem. The proto...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Binding Sites
Share to DEAD-box RNA Helicases
Share to Drug Delivery Systems

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Nuclear Magnetic Resonance, Biomolecular

Share to Protein Binding

Share to Sterols

Source

Open in PubMed Open full text

Identifiers

PMID: 18270573
DOI: 10.1371/journal.pone.0001583
PMCID: PMC2216682

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18270573-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Selective pharmacological targeting of a DEAD box RNA helicase.PMID 18270573Read ↗

Identification and characterization of hippuristanol-resistant mutants reveals eIF4A1 dependencies within mRNA 5' leader regions.Semantic proximity Read ↗

CRISPR-Mediated Drug-Target Validation Reveals Selective Pharmacological Inhibition of the RNA Helicase, eIF4A.Semantic proximity Read ↗

<i>In silico</i> , biochemical, and <i>in vitro</i> analysis of silvestrol binding to the DEAD box RNA helicase eIF4A reveals broad anti-pathogen potential of rocaglates across the eukaryotic tree of lifeSemantic proximity Read ↗

The RNA helicase eIF4A as a novel target in insect cells to combat arboviral infectionsSemantic proximity Read ↗

Targeting the DEAD-Box RNA Helicase eIF4A with Rocaglates—A Pan-Antiviral Strategy for Minimizing the Impact of Future RNA Virus PandemicsSemantic proximity Read ↗

Should We Try SARS-CoV-2 Helicase Inhibitors for COVID-19 Therapy?Semantic proximity Read ↗

Modular RNA-based PROTACs for selective degradation of multidomain RNA-binding proteinsSemantic proximity Read ↗

CRISPR-Based Screen Links an Inhibitor of Nonsense-Mediated Decay to eIF4A3 Target Engagement.Semantic proximity Read ↗

Recent Development of Aminoacyl-tRNA Synthetase Inhibitors for Human Diseases: A Future PerspectiveSemantic proximity Read ↗

Small molecule induced STING degradation facilitated by the HECT ligase HERC4.Semantic proximity Read ↗

Small molecule targeting CELF1 RNA-binding activity to control HSC activation and liver fibrosisSemantic proximity Read ↗

A second-generation eIF4A RNA helicase inhibitor exploits translational reprogramming as a vulnerability in triple-negative breast cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.